Skip to main content
Log in

Prediction of late restenosis after sirolimus-eluting stent implantation using serial quantitative angiographic and intravascular ultrasound analysis

  • Original Article
  • Published:
Cardiovascular Intervention and Therapeutics Aims and scope Submit manuscript

Abstract

Although sirolimus-eluting stents (SESs) have shown to significantly reduce the incidence of restenosis, it remains unclear when the follow-up angiography should be performed after SES implantation. A total of 868 patients with 1,574 lesions were treated with SES. Of the 71 patients with 87 lesions were performed serial angiographic and intravascular ultrasound (IVUS) analysis (pre, post, 1st and 2nd-follow-up). The first follow-up period was 7.9 ± 3.5 months and the second follow-up was 18.9 ± 7.7 months. Late restenosis (LR) was defined as diameter stenosis ≥50% at second follow-up, which was <50% at first follow-up. A total of restenosis was documented in 69 patients with 89 lesions (5.7%) overall, 13 lesions (3.2%) led to LR. Angiographic pattern of LR was predominately focal pattern. In LR group, late lumen loss by angiography was increased between 1st-follow-up and 2nd-follow-up (0.69 ± 0.41 mm in first follow-up and 1.98 ± 0.44 mm in second follow-up, p < 0.0001). Minimum lumen area (MLA) by IVUS had slightly decreased already in 1st-follow-up (6.07 ± 2.31 mm2 in post procedure and 4.71 ± 2.05 mm2 in 1st-follow-up, p = 0.098) and significantly decreased in 2nd-follow-up (6.07 ± 2.31 mm2 in post procedure and 1.71 ± 0.93 mm2 in 2nd-follow-up, p < 0.0001). However, in each period, there were no significant difference in both late lumen loss and MLA in non-LR group. Neointima growth prolonged gradually over 1 year in LR group. These findings suggest that if neointimal proliferation is recognized in short-term-follow-up period, long-follow-up should be needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

LR:

Late restenosis

MLA:

Minimum lumen area

TLR:

Target lesion revascularization

LST:

Late stent thrombosis

References

  1. Morice M-C, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, RAVEL study group, et al. A randomized comparison of a sirolimus-eluting stent with a standard s tent for coronary revascularization. N Engl J Med. 2002;346:1773–80.

    Article  CAS  PubMed  Google Scholar 

  2. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, Caputo RP, SIRIUS investigators, et al. Sirolimus-eluting stents versus standard stent in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–23.

    Article  CAS  PubMed  Google Scholar 

  3. Schofer J, Schluter M, Gershilick AH, Wijns W, Garcia E, Schampaert E, Breithardt G, E-SIRIUS investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet. 2003;362:1093–9.

    Article  CAS  PubMed  Google Scholar 

  4. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM, Kuntz RE, C-SIRIUS investigators, et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol. 2004;43:1110–5.

    Article  CAS  PubMed  Google Scholar 

  5. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, Turco M, TAXUS-IV investigators, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004;109:1942–7.

    Article  CAS  PubMed  Google Scholar 

  6. Virmani R, Liistro F, Stankovic G, Di Mario C, Montorfano M, Farb A, Kolodgie FD, et al. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation. 2002;106:2649–51.

    Article  CAS  PubMed  Google Scholar 

  7. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, et al. Pathology of drug-eluting stents in humans: delayed healin g and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202.

    Article  PubMed  Google Scholar 

  8. Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HK, Virmani R. Vascular responses to drug eluting stents: importance of delayed dealing. Arteroscler Thromb Vasc Biol. 2007;27:1500–10.

    Article  CAS  Google Scholar 

  9. Aoki J, Abizaid AC, Serruys PW, Ong AT, Boersma E, Sousa JE, Bruining N. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients. J Am Coll Cardiol. 2005;46:1670–6.

    Article  PubMed  Google Scholar 

  10. Cosgrave J, Corbett SJ, Melzi G, Babic R, Biondi-Zoccai GG, Airoldi F, Chieffo A, et al. Late restenosis following sirolimus-eluting stent implantation. Am J Cardiol. 2007;100:41–4.

    Article  PubMed  Google Scholar 

  11. Mehran R, Dangas G, Abizaid AS, Mints GS, Lansky AJ, Satler LF, Pichard AD, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation. 1999;100:1872–8.

    CAS  PubMed  Google Scholar 

  12. Sousa JE, Costa MA, Abizaid A, Feres F, Seixas AC, Tanajura LF, Mattos LA, et al. Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents. Circulation. 2005;111:2326–9.

    Article  CAS  PubMed  Google Scholar 

  13. Hong MK, Mintz GS, Lee CW, Park DW, Lee SW, Kim YH, Jung IH, et al. Late target lesion revascularization after implantation of sirolimus-eluting stent. Catheter Cardiovasc Interv. 2008;71:299–303.

    Article  PubMed  Google Scholar 

  14. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, McFadden E, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital (RESERCH) study. Circulation. 2004;109:1366–70.

    Article  PubMed  Google Scholar 

  15. Holmes DR, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerand PJ, Brown C, et al. Analysis of 1-year clinical outcomes in the SIRIUS Trial. A randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004;109:634–40.

    Article  PubMed  Google Scholar 

  16. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, Liistro F, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation. 2003;107:2178–80.

    Article  PubMed  Google Scholar 

  17. Lemos PA, Saia F, Ligthart JM, Arampatzis CA, Sianos G, Tanabe K, Hoye A, et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 2003;108:257–60.

    Article  PubMed  Google Scholar 

  18. Kitahara H, Kobayashi Y, Takebayashi H, Nakamura Y, Kuroda N, Miyazaki A, Haruta S, et al. Angiographic patterns of restenosis after sirolimus-eluting stent implantation. Circ J. 2009;73:508–11.

    Article  CAS  PubMed  Google Scholar 

  19. Solinas E, Dangas G, Kirtane AJ, Lansky AJ, Franklin-Bond T, Boland P, Syros G, et al. Angiographic patterns or drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention. Am J Cardiol. 2008;102:311–5.

    Article  CAS  PubMed  Google Scholar 

  20. Shiratori Y, Oikawa Y, Yajima J. “Black Hole” restenosis after sirolimus-eluting stent implantation. J Invasive Caridol. 2008;20:E253–5.

    Google Scholar 

  21. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–30.

    Article  CAS  PubMed  Google Scholar 

  22. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, Escaned J, et al. Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol. 2005;45:954–9.

    Article  CAS  PubMed  Google Scholar 

  23. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol. 2005;45:2088–92.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank all members of the cardiovascular institute and the catheter laboratory; Mr. Eiji Noguchi, Ms. Erika Miura, and Ms. Yoshie Takanashi, for their valuable suggestions and advice in the measurement of data.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ryuichi Funada.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Funada, R., Oikawa, Y., Yajima, J. et al. Prediction of late restenosis after sirolimus-eluting stent implantation using serial quantitative angiographic and intravascular ultrasound analysis. Cardiovasc Interv and Ther 26, 26–32 (2011). https://doi.org/10.1007/s12928-010-0030-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12928-010-0030-3

Keywords

Navigation